We Donate

We are 100% committed.

Today, ovarian cancer is practically a death sentence. Survival rates over the last five years remain low and unchanged at 35%. Not enough is being done to advance an agenda on behalf of ovarian cancer patients, families and those who have gone before. We’re working to change that!


The Barbara T. Foundation sees its role in the fight against ovarian cancer as an urgent agent of change to turn the tide against this tragic, horrible disease. We are an army of volunteer advocates, experts and medical professionals who give of our time so that every penny of our funding goes into preventing, detecting and curing ovarian cancer.

That’s why we’re all in when it comes to our work in her name. By focusing 100% of our time and resources on the prevention, detection and cure of ovarian cancer, we are funding the most urgent pathways to a breakthrough. We do so while driving strategic advocacy in service to fast-tracking increased survival rates and a cure. We are also 100% practical. We seek to advance solutions that stem the tide today while advancing to a cure as soon possible.

In all of it, we are committed to directing 100% of donations to those doing the work. To that end, we are a 100%-volunteer organization.

The Barbara T. Foundation focuses its funding across three areas: detection, prevention and a cure for ovarian cancer.

At this nascent stage of our development, we are currently sending 100% direct support to the University of Texas MD Anderson Cancer Center (Houston). Our monies are helping underwrite the Centers Ovarian Cancer Moon Shot® that is focused on finding a cure for high-grade and low-grade serous ovarian cancer by rapidly adapting pre-clinical findings into new treatment options.

We are also considering future funding directions at MD Anderson that include, but are not limited to:

  • The Blanton-Davis Ovarian Cancer Research Program that leverages a multi-disciplinary integration of research, patient care, education and prevention initiatives focused on ovarian cancer.
  • SPOR (Specialized Programs of Research Excellence)
  • The Low-Grade Serous Ovarian Cancer Program that focuses on cutting-edge laboratory and clinical investigations leading to novel therapies, with the goal of improving outcomes for women with this rare ovarian cancer subtype.
  • The Early Detection & Prevention Effort that focuses developing novel strategies to detect ovarian cancer in its earliest stages. Innovative prevention efforts, especially for high-risk women, are also being tested.

 PLEASE, if you have a heart for Ovarian Cancer, PLEASE DONATE NOW!